How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy?
Alarcón
Graciela S
GS
University of Alabama at Birmingham, Birmingham, AL, USA.
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis*
D000962:Antimalarials; D006886:Hydroxychloroquine